What the MHRA has approved
The Wegovy pill is oral semaglutide, the same drug as the Wegovy injection in tablet form.1
The MHRA has licensed it for adults with a body mass index (BMI) of 30 or above, or 27 to 30, alongside at least one weight-related condition, such as type 2 diabetes or high blood pressure.1
Like the injection, it’s meant to be used with a reduced-calorie diet and more physical activity, not on its own.
The dose builds up gradually. It starts at 1.5 mg per day, then steps up to 4 mg, then 9 mg, and finally to a maintenance dose of 25 mg, with at least a month between each increase.1
That slow build-up is the same principle as the injection, and it’s there to help your body adjust and keep side effects to a minimum.
The most common side effects are gut-related, including nausea, diarrhoea, constipation, and vomiting, as with the injection.1
The Wegovy pill is prescription-only, so a prescriber must confirm it’s suitable for you before you can take it.1
How well the Wegovy pill works
In OASIS 4, the trial that led to approval, the Wegovy pill produced an average weight loss of 13.6% over 64 weeks, compared with 2.2% on placebo.2
That’s almost the same as the standard 2.4 mg Wegovy injection, which produced 13.7% in SURMOUNT-5, the trial that directly compared it with Mounjaro.3
It produces less weight loss than the strongest injectable options. Mounjaro produced a 20.2% weight loss in that same comparison, and the higher-dose 7.2 mg Wegovy injection produced an average weight loss of 20.7% in the STEP UP trial.3,4
Our guide to the Wegovy pill vs the Wegovy injection goes through these numbers in more detail.
How you take the Wegovy pill
You take the tablet whole when you wake up, on an empty stomach, with only a sip of plain water.1
You then wait at least 30 minutes before any food or other drinks.1
Oral semaglutide is absorbed in the stomach with the help of an added ingredient called SNAC, and food or extra fluid reduces how much of the drug gets through.
For many people, that routine is easy to build into the morning. For others, particularly those whose wake-up time varies or who take other tablets first thing, a weekly injection may be easier to stick to.
If the strict dosing protocols of the Wegovy pill aren’t met consistently, the drug won’t be as effective.
How to get it, and why it isn’t on the NHS
The MHRA approval means the Wegovy pill can now be prescribed in the UK. For now, that’s through private providers, in the same way the Wegovy and Mounjaro injections first became available.
Novo Nordisk, the company that makes Wegovy, has said it expects the pill to be available through private providers within weeks.
However, it isn’t funded by the NHS yet. The MHRA has confirmed that NHS use will follow its usual process, including an evaluation by NICE, the body that decides which treatments the NHS pays for.1
The Wegovy injection is available on the NHS through specialist weight management services, but that recommendation doesn’t cover the pill.5
NICE hasn’t recommended oral semaglutide for weight management, so there’s no NHS route at launch and no confirmed timeline for one.
If you’d like us to let you know when private access opens, you can join the waiting list on our Wegovy pill guide.
What it means if you’re already on an injection
The MHRA has said that people treated privately with the 2.4 mg weekly Wegovy injection can move directly to the 25 mg daily tablet, without building back up from the lowest dose.1
Because the tablet matches that standard injection for weight loss, the choice there is mostly about whether you’d prefer a daily tablet or a weekly injection.
If you’re happy with your current treatment, there’s no reason to switch. If Mounjaro or Wegovy injections are helping you reach your goals and the cost works for you, the most effective option is the one you’re already on.
But the pill may be suitable if:
- You strongly dislike injections
- You’re a frequent traveller and value convenience over weight loss results
- You’re thinking about long-term maintenance rather than further weight loss
- You’ve reached your goal and want to start coming off medication
If this isn’t you, we’d recommend continuing with your current treatment.
Whatever you decide, the safest approach is to plan any change with your prescriber rather than stopping one medication on your own.
Pills may be better for those who are needle-averse
For some people, a fear of needles is what has put them off weight-loss medication altogether. A daily tablet removes that barrier and makes treatment an option for more people.
It also fits more easily around travel and storage, since there’s no pen to keep refrigerated.
The pill is a like-for-like alternative to the standard injection, not a more effective one, so it changes who can start treatment more than it changes the results for people already doing well on an injection.
The Wegovy pill is also the first oral GLP-1 licensed for weight loss in the UK, and others are expected to follow.
Foundayo (orforglipron), a GLP-1 tablet that can be taken with or without food, was approved in the U.S. in April 2026 but isn’t yet approved by the MHRA.
Our Foundayo guide covers how it works and when it might reach the UK.
Frequently asked questions
Is the Wegovy pill available in the UK now?
The MHRA approved the Wegovy pill on 11th June 2026, and Novo Nordisk has said it expects it to be available through private providers within weeks.1
You can join the waiting list to learn when private access opens.
Will the Wegovy pill be available on the NHS?
Not yet. NHS use will follow the usual process, including an evaluation by NICE, and there’s no confirmed timeline for a decision.1
The Wegovy injection is available through NHS specialist weight management services, but that recommendation doesn’t cover the pill.5
How much weight do you lose on the Wegovy pill?
In the OASIS 4 trial, the Wegovy pill produced an average weight loss of 13.6% over 64 weeks, compared with 2.2% on placebo.2
Among participants who stayed on the pill and reached the full 25 mg dose, average weight loss was 16.6%.2
How do you take the Wegovy pill?
You take one tablet whole when you wake up, on an empty stomach, with a sip of plain water, then wait at least 30 minutes before eating or drinking anything else.1
The dose starts at 1.5 mg a day and builds up to a maintenance dose of 25 mg, with at least a month at each step.1
Can I switch from the Wegovy injection to the pill?
The MHRA has said that people treated privately with the 2.4 mg weekly injection can move straight to the 25 mg daily tablet, without building up from the lowest dose.1
Any switch is best planned with your prescriber rather than made on your own.
Is the Wegovy pill the same as Rybelsus?
No. Both contain oral semaglutide, but Rybelsus is licensed for type 2 diabetes at doses up to 14 mg, while the Wegovy pill is licensed for weight management at 25 mg.
Our Wegovy vs Rybelsus guide covers the differences in detail.
What are the side effects of the Wegovy pill?
The most common side effects are gut-related, including nausea, diarrhoea, constipation, and vomiting.1
In OASIS 4, 74% of people taking the pill reported gut side effects, compared with 42% on placebo.2
How is the Wegovy pill different from Foundayo?
Foundayo (orforglipron) is a different drug that can be taken at any time of day, with or without food, but it isn’t yet approved in the UK.
Our guide to the Wegovy pill vs Foundayo compares the two in detail.
Take home message
The Wegovy pill is the first GLP-1 weight-loss tablet approved in the UK, and it provides more weight-loss treatment options for those living with obesity, particularly those who are needle averse.
On the evidence so far, it supports similar weight loss to the Wegovy 2.4 mg injection.
It’s licensed and will be available via private prescription in early July, but it won’t be available on the NHS yet.
Second Nature’s medication programme combines Mounjaro with structured nutrition guidance from registered dietitians, built around the balanced plate model (half vegetables, quarter protein, quarter complex carbohydrates such as wholegrain bread, brown rice, or oats, plus a serving of fat).
Our peer-reviewed JMIR study of the GLP-1-supported programme reported an average weight loss of 19.1% at 12 months among active subscribers, with 77.7% achieving at least 10% weight loss.6
Second Nature's Mounjaro and Wegovy programmes
Second Nature provides Mounjaro or Wegovy as part of our Mounjaro and Wegovy weight-loss programmes.
Why choose Second Nature over other medication providers, assuming you're eligible?
Because peace of mind matters.
We've had the privilege of working with the NHS for over eight years, helping people across the UK take meaningful steps toward a healthier, happier life.
Our programmes are designed to meet people where they are, whether that means support with weight loss through compassionate one-to-one health coaching, or access to the latest weight-loss medications (like Mounjaro and Wegovy) delivered alongside expert care from a multidisciplinary team of doctors, psychologists, dietitians, and personal trainers.
At the heart of everything we do is a simple belief: real, lasting change comes from building better habits, not relying on quick fixes. We're here to support that change every step of the way.
With over a decade of experience, thousands of lives changed, and a long-standing record of delivering programmes used by the NHS, we believe we're the UK's most trusted weight-loss programme.
We hope to offer you something invaluable: peace of mind, and the support you need to take that first step.
